Example: Heart Attack

Clinical Trials on Leukemia

Total 6537 results

NCT03624270

Recruiting

Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia

Conditions: Acute Promyelocytic Leukemia
NCT03751917

Recruiting

Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Leukemia

Conditions: Acute Promyelocytic Leukemia
NCT00482833

Unknown status

Phase III Trial in Acute Promyelocytic Leukemia Patients

Conditions: Leukemia
NCT00528450

Terminated

Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia

Conditions: Leukemia
NCT03096496

Unknown status

Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy

Conditions: Acute Promyelocytic Leukemia
NCT04028531

Recruiting

Understanding Chronic Lymphocytic Leukemia

Conditions: Chronic Lymphocytic Leukemia
NCT04439721

Recruiting

γδT Cell Infusion to Prevent Relapsed/Refractory Leukemia Rescue Relapse

Conditions: Leukemia, B-cell
NCT02899169

Unknown status

Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF)

Conditions: Acute Promyelocytic Leukemia
NCT02735291

Active, not recruiting

Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemia

Conditions: Leukemia
NCT00492856

Completed

S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia

Conditions: Leukemia
NCT03058588

Recruiting

Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes

Conditions: Leukemia
NCT03594955

Recruiting

First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome

Conditions: Leukaemia
NCT03876834

Completed

Respiratory Training in Patients With Leukemia

Conditions: Leukemia
NCT04158011

Active, not recruiting

A Retrospective Study of Patients With Leukemia Relapse in the CNS Treated With CAR T Cells

Conditions: Acute Lymphoblastic Leukemia
NCT00002701

Unknown status

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia

Conditions: Leukemia
NCT02345382

Completed

Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia

Conditions: Leukemia
NCT00777036

Active, not recruiting

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Conditions: Leukemia
NCT01214603

Completed

A Study in Participants With Acute Leukemia

Conditions: Leukemia
NCT01500499

Completed

Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia

Conditions: Leukemia
NCT02305563

Terminated

An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia

Conditions: Leukemia
NCT00609739

Terminated

Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation

Conditions: Leukemia
NCT02251548

Active, not recruiting

A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia

Conditions: Chronic Lymphocytic Leukemia; Leukemia
NCT04251754

Recruiting

The Acute Promyelocytic Leukaemia Asian Consortium (APL-AC) Project

Conditions: Acute Promyelocytic Leukemia
NCT01227135

Unknown status

Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia

Conditions: Leukemia
NCT00686218

Completed

Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia

Conditions: Leukemia